CD276 and cervical cancer: TISIDB was employed to examine immune infiltration in cervical cancer, revealing that IDO1 levels exhibit a significantly positive association with ICOS, C10orf54, CD27, CD28, CD70, and other immunostimulatory factors, which negatively regulate the expression of CD276.